Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss

NCT00637572 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections
Cachexia
Anorexia
AIDS Wasting Syndrome
HIV Wasting Syndrome

Interventions

DRUG: Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL
DRUG: Megestrol acetate oral suspension 40 mg/mL

Sponsor

Endo Pharmaceuticals

Collaborators

[object Object]